Overview

Timing of Postpartum Depot Medroxyprogesterone Acetate Administration on Breastfeeding, Contraceptive Continuation, and Depression

Status:
Completed

Trial end date:
2017-10-16

Target enrollment:

Participant gender:

Summary

The investigators plan to enroll 184 women who are planning to breastfeed and use DMPA after delivery to find out whether the timing of postpartum administration of DMPA (prior to hospital discharge or 4-6 weeks after delivery) affects the duration or exclusivity of breastfeeding among women who plan to breastfeed their infants.

Phase:

Phase 4

Details

Lead Sponsor:

Beatrice Chen
University of Pittsburgh

Collaborator:

Society of Family Planning

Treatments:

Contraceptive Agents
Medroxyprogesterone
Medroxyprogesterone Acetate